IL25494A - Pregnano(17alpha,16alpha-d)oxazolines - Google Patents

Pregnano(17alpha,16alpha-d)oxazolines

Info

Publication number
IL25494A
IL25494A IL25494A IL2549466A IL25494A IL 25494 A IL25494 A IL 25494A IL 25494 A IL25494 A IL 25494A IL 2549466 A IL2549466 A IL 2549466A IL 25494 A IL25494 A IL 25494A
Authority
IL
Israel
Prior art keywords
pregnano
16alpha
17alpha
oxazolines
Prior art date
Application number
IL25494A
Other languages
English (en)
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of IL25494A publication Critical patent/IL25494A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0027Azides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/0025Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
    • C07J7/0035Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a hydroxy group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0057Nitrogen and oxygen
    • C07J71/0068Nitrogen and oxygen at position 16(17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Machines (AREA)
IL25494A 1965-04-22 1966-03-30 Pregnano(17alpha,16alpha-d)oxazolines IL25494A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB17027/65A GB1077392A (en) 1965-04-22 1965-04-22 New steroids
GB3586565 1965-08-20

Publications (1)

Publication Number Publication Date
IL25494A true IL25494A (en) 1970-03-22

Family

ID=26252388

Family Applications (2)

Application Number Title Priority Date Filing Date
IL25494A IL25494A (en) 1965-04-22 1966-03-30 Pregnano(17alpha,16alpha-d)oxazolines
IL25493A IL25493A (en) 1965-04-22 1966-03-30 Pregnano(17alpha,16alpha-d)oxazolines

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL25493A IL25493A (en) 1965-04-22 1966-03-30 Pregnano(17alpha,16alpha-d)oxazolines

Country Status (15)

Country Link
US (2) US3436389A (es)
AT (2) AT260440B (es)
BE (2) BE679820A (es)
BR (2) BR6678805D0 (es)
CH (2) CH471833A (es)
DE (3) DE1568950A1 (es)
DK (2) DK116870B (es)
ES (1) ES325755A1 (es)
FI (2) FI44905C (es)
FR (1) FR5645M (es)
GB (1) GB1077392A (es)
IL (2) IL25494A (es)
NL (3) NL6605174A (es)
NO (2) NO127346B (es)
SE (2) SE323675B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1119081A (en) * 1966-01-11 1968-07-10 Lepetit Spa New steroids
IT1141930B (it) * 1980-04-28 1986-10-08 Lepetit Spa Esteri idrosolubili di steroido-ossazoli e loro composizioni farmaceutiche
IT1134455B (it) * 1980-11-26 1986-08-13 Lepetit Spa Procedimento per la preparazione di derivati 16alfa-idrossi-17alfa-aminopregnanici
AR045536A1 (es) * 2003-08-29 2005-11-02 Ranbaxy Lab Ltd Inhibidores de la fosfodiesterasa tipo -iv
WO2005051931A2 (en) * 2003-11-26 2005-06-09 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US20080009535A1 (en) * 2004-08-30 2008-01-10 Sarala Balachandran Inhibitors of phosphodiesterase type-IV
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
WO2007045980A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
CA2626612A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
WO2008035315A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
CN101177443B (zh) * 2006-11-09 2011-08-03 天津药业研究院有限公司 新的甾体化合物及其应用
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
CN103497185A (zh) 2007-03-14 2014-01-08 兰贝克赛实验室有限公司 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物
EP2124943A1 (en) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2874154A (en) * 1954-10-15 1959-02-17 Syntex Sa Process for the production of 20-keto-21-iodo steroids
US2923721A (en) * 1955-12-13 1960-02-02 Lab Francais Chimiotherapie Method of preparing 3-keto delta1, 4 steroids
DE1223376B (de) * 1963-12-14 1966-08-25 Hoechst Ag Verfahren zur Herstellung von 17alpha-Cyan-16alpha-hydroxy-steroiden der Pregnanreihe
US3349084A (en) * 1965-05-17 1967-10-24 Upjohn Co Steroidal [16, 17-d]-2'-isoxazolines of the pregnane series

Also Published As

Publication number Publication date
IL25493A (en) 1969-12-31
BR6678805D0 (pt) 1973-09-18
CH471833A (fr) 1969-04-30
GB1077392A (en) 1967-07-26
AT265539B (de) 1968-10-10
DE1793662A1 (de) 1972-08-03
FR5645M (es) 1967-12-26
SE323675B (es) 1970-05-11
NL128816C (es)
FI44906C (fi) 1972-02-10
FI44905C (fi) 1972-02-10
DK116870B (da) 1970-02-23
US3436389A (en) 1969-04-01
NL6605174A (es) 1966-10-24
SE323674B (es) 1970-05-11
FI44906B (es) 1971-11-01
NO127346B (es) 1973-06-12
BR6679615D0 (pt) 1973-10-23
DK117631B (da) 1970-05-19
AT260440B (de) 1968-03-11
US3413286A (en) 1968-11-26
NL6605375A (es) 1966-10-24
DE1568950A1 (de) 1970-11-26
BE679820A (es) 1966-10-03
ES325755A1 (es) 1967-02-16
BE679821A (es) 1966-10-03
DE1793662B2 (de) 1973-04-19
DE1568951A1 (de) 1970-06-18
NO128152B (es) 1973-10-08
DE1793662C3 (de) 1973-11-08
FI44905B (es) 1971-11-01
CH453351A (fr) 1968-06-14

Similar Documents

Publication Publication Date Title
IL25494A (en) Pregnano(17alpha,16alpha-d)oxazolines
IL27028A (en) 11beta-hydroxy-pregnano (17alpha,16alpha-d)-oxazolines
AU400515B2 (en) 6-substituted-methyl-4, 6-dien-3-ones
CA701600A (en) 20-hydroxy-18,20-cyclosteroids
CA702532A (en) 1-aryl-cycloaliphatic-1,2-dicarboximides
AU408313B2 (en) 17-OXYGENATED-5-ANDROSTAN-2d,3d-EPISULFIDES
AU291183B2 (en) 16-halogenated-9b, 10-pregnanes
IL27162A (en) 6-cyano-3,5-pregnadienes
YU85266A (en) Elektromagnetsko upravljana stikalna proprava, posebno kontaktor
IE29114L (en) 9ß, 10Ó-STEROIDS
IE28849L (en) 9ß, 10Ó-METHYL-STEROIDS
IE29203L (en) 9ß, 10Ó-STEROIDS
IE29144L (en) 9ß, 10Ó-STEROIDS
IE29115L (en) 16-HALO-9ß, 10Ó-PREGNANES
IE29116L (en) 9ß, 10Ó-STEROIDS
CA707578A (en) Back rest
CA707577A (en) Back rest
CA709392A (en) 2,4-diamino-5-bromo-6-chloropyrimidines
CA708957A (en) 2,2-difluorothiiranes
CA714055A (en) 3,4-epithiosteroids
CA720364A (en) 1,2,5-thiadiazole-3-hydrazides
CA708942A (en) 1,2-thiazetidine-3-one-1-oxides
CA708609A (en) 2,3-epithio-steroid
CA708178A (en) 16,17-epithiosteroid
CA706892A (en) 2,4-diamino-6-hydroxymethyl-7,8-dihydropteridine